Transcat, Inc. TRNS
87.73
1.60
1.86%
as of 25 Sep
- Market cap
- $806.2M
- P/E
- 237×
Follow TRNS
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
250.73 | 126.64 | 66.74 | 59.51 |
+8 more quarters Free account |
P/S ratio |
2.49 | 2.07 | 1.66 | 2.25 | |
P/FCF ratio |
34.21 | 35.06 | 21.28 | 26.01 | |
P/Operating CF |
98.41 | 110.56 | 43.58 | 52.97 | |
P/B ratio |
2.86 | 2.28 | 1.78 | 2.31 | |
Price to Tangible BV |
0.00 | 145.00 | 0.00 | 0.00 | |
EV/Sales |
2.79 | 2.36 | 1.96 | 2.61 | |
EV/EBITDA |
24.74 | 19.77 | 15.37 | 19.73 | |
EV/Operating CF |
24.29 | 22.43 | 15.96 | 19.89 | |
EV/FCF |
38.35 | 39.98 | 25.20 | 30.12 | |
Quick Ratio |
1.93 | 1.79 | 1.73 | 1.93 | |
Current Ratio |
2.49 | 2.33 | 2.21 | 2.43 | |
Net Debt/EBITDA |
9.67 | 8.39 | 13.29 | 10.66 | |
Debt/Assets |
22.41% | 20.79% | 21.12% | 23.07% | |
Debt/Equity |
0.36 | 0.33 | 0.34 | 0.38 | |
Asset Turnover |
0.79 | 0.77 | 0.74 | 0.75 | |
Operating CF/Net income |
6.62 | 3.18 | (11.03) | 10.15 | |
Capex/Depreciation |
(0.57) | (0.51) | (0.37) | (0.68) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
29.07% | 29.26% | 30.01% | 28.27% | |
Intangible Assets out of Total Assets |
0.62 | 0.62 | 0.63 | 0.63 | |
Share Based Compensation of Revenue |
2.13% | 2.82% | 2.46% | 2.24% | |
Graham Net Nets |
(0.11) | (0.13) | (0.18) | (0.15) | |
Graham Number |
16.42 | 20.50 | 24.67 | 29.62 | |
Earnings Yield |
0.40% | 0.79% | 1.50% | 1.68% | |
Free Cash Flow Yield |
2.92% | 2.85% | 4.70% | 3.85% | |
Revenue per Share |
9.94 | 9.57 | 8.99 | 8.83 | |
Operating CF per Share |
0.94 | 0.66 | 1.30 | 1.38 | |
Capex per Share |
(0.43) | (0.38) | (0.29) | (0.48) | |
Free Cash Flow per Share |
0.52 | 0.28 | 1.01 | 0.91 | |
Cash per Share |
0.72 | 0.53 | 0.37 | 0.55 | |
Shareholders Equity per Share |
32.39 | 32.21 | 31.81 | 31.69 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
32.39 | 32.21 | 31.81 | 31.69 | |
Free Cash Flow |
4.84 | 2.61 | 9.47 | 8.45 | |
Working Capital |
57.32 | 52.83 | 44.19 | 50.44 | |
Capital Expenditures |
(3.98) | (3.59) | (2.68) | (4.43) | |
Net Current Asset Value |
(93.99) | (87.41) | (95.31) | (103.72) | |
EV/EBIT |
83.53 | 58.94 | 39.50 | 44.19 | |
Capex to Sales |
0.04 | 0.04 | 0.03 | 0.05 | |
Net Profit Margin |
1.43% | 2.18% | (1.31%) | 1.54% | |
Price to Operating Income |
74.52 | 51.69 | 33.35 | 38.15 | |
| Other line items | |||||
Average Receivables |
62.92 | 61.08 | 56.07 | 56.39 | |
Average Payables |
16.88 | 17.34 | 16.84 | 14.21 | |
Average Inventory |
15.08 | 14.09 | 13.35 | 14.31 | |
Average Assets |
442.58 | 432.86 | 429.45 | 404.22 | |
Average Common Equity |
297.72 | 293.75 | 288.93 | 282.09 |
Columns are period end dates